Budget Impact Analysis Of Adopting Evolocumab In The Brazilian Private Healthcare System For Patients With Uncontrolled LDL-C And High Cardiovascular Risk

Oct 1, 2017, 00:00 AM
10.1016/j.jval.2017.08.2838
https://www.valueinhealthjournal.com/article/S1098-3015(17)33172-8/fulltext
Section Title : Disease-Specific Studies
Section Order : 2588
First Page : A914
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)33172-8&doi=10.1016/j.jval.2017.08.2838
HEOR Topics :
Tags :
Regions :